Home/Filings/4/0001437749-24-033703
4//SEC Filing

KLEMP WALTER V 4

Accession 0001437749-24-033703

CIK 0001659617other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 8:00 PM ET

Size

10.5 KB

Accession

0001437749-24-033703

Insider Transaction Report

Form 4
Period: 2024-10-25
KLEMP WALTER V
DirectorCEO and President
Transactions
  • Award

    Stock option (right to buy)

    2024-11-04+100,000213,152 total
    Exercise: $2.45Exp: 2024-11-04Common Stock (100,000 underlying)
  • Award

    Restricted Stock Units

    2024-11-04+115,000328,152 total
    Common Stock (115,000 underlying)
  • Award

    Performance Based Restricted Stock Units

    2024-10-25+43,590371,742 total
    Exp: 2033-12-29Common Stock (43,590 underlying)
Footnotes (5)
  • [F1]The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.
  • [F2]Issued in connection with the reporting person's employment with the Company.
  • [F3]Each restricted stock unit represents a contingent right to receive one shares of Company common stock.
  • [F4]The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.
  • [F5]On December 29, 2023, the Board approved this performance based restricted stock unit, subject to shareholder approval of the stock plan. The performance based restricted stock units set forth in this table will vest only upon both (A) the approval of the Plan Amendment by the Company stockholders; and (B) the first of the following to occur: (a) a licensing transaction with a valuation, at the time, in excess of $150 million, which valuation shall be determined by the Board; (b) the filing of a new drug application; or (c) upon a Change in Control (as defined in the Plan), in each case subject to the respective executive officer's continued service with the Company at each such vesting date.

Issuer

Moleculin Biotech, Inc.

CIK 0001659617

Entity typeother

Related Parties

1
  • filerCIK 0000938419

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 8:00 PM ET
Size
10.5 KB